16 ACPE Credits
16.0 Contact Hours
2¾ Hours of Pharmacology for NPs
Course Fees:$995 for Physicians, Attorneys, Psychologists, Pharmacists, & Dentists
$750 for Physician Assistants
$750 for Nurse Practitioners
$595 for Nurses, Students & Others
BIAS FREE CME - No Commercial Support was provided for this CME activity.
It is estimated that currently 54.4 million U.S. adults suffer from doctor diagnosed arthritis - equating to about 25% of the population. This number is projected to increase to 78 million by 2040. Arthritis is the leading cause of disability, and the most common types are osteoarthritis, rheumatoid arthritis, gout, lupus, and fibromyalgia. In addition, there is a major health care crisis in bone health and epidemic of fractures due to osteoporosis leading to significant morbidities, mortality and costs.
Yet, there remains a significant gap between the awareness of these disorders as well as ability to appropriately diagnose and manage rheumatic disorders in medical community. There have been a lot of advancements in appropriately diagnosing and classifying as well as managing these disorders with an explosion of therapeutic options. These advancements are yet to be used widely in practice and there exists a huge gap.
These lectures provide a huge opportunity in learning how to better diagnose these disorders and choose appropriate therapeutic options. They also provide an opportunity to learn and understand evidence based guidelines published in these disorders for classification and management of these disorders. The desired outcomes in audience is better understanding of these very common disorders to improve their ability to diagnose and differentiate from other mimickers and also manage them appropriately.Topics:
- Evaluation and management of Osteoarthritis.
- Identify that osteoarthritis(OA) is most common form of arthritis and has an immense impact on lives in USA.
- Describe various clinical manifestations of OA.
- Select the various management options based upon the evidence based guidelines provided by various professional organization.
- Update on diagnosis and management of Rheumatoid Arthritis.
- Elucidate the epidemiology of Rheumatoid Arthritis(RA).
- Differentiate Inflammatory from non-inflammatory arthritis.
- Recognize various clinical presentations of RA and its classification criteria.
- Describe common agents used to treat and evidence based strategies in management of RA.
- Gout in 21st century: How far have we come?
- Identify the recent updates in the evaluation and management of Gout.
- Ascertain the role of uric acid in pathogenesis and management of Gout.
- Distinguish the differing positions of American College of Rheumatology and American College of Physicians in management of Gout.
- Describe therapeutic options for management of Gout and potential pitfalls.
- Osteoporosis: A Silent Killer; Current state of evaluation and management.
- Identify the recent updates in the evaluation and management of Osteoporosis.
- Describe the role of bone density testing in evaluation of Osteoporosis.
- Discuss recent advances including a new therapeutic options on horizon for management of Osteoporosis.
- Inflammatory Back Pain: How to evaluate spondyloarthritides and manage them?
- Differentiate clinical presentation and common features of mechanical back pain from inflammatory back pain.
- Ascertain various clinical presentations and classification of Spondyloarthritides (SpA).
- Discover the available therapeutic options and guidelines for management of axial and peripheral SpA.
- Connective Tissue Disease: What does it mean? How is it evaluated and when do I get rheumatology involved?
- Conclude that a positive test for auto-antibodies does not mean a diagnosis of autoimmune diseases.
- Describe common auto-antibodies and their association with underlying diseases.
- Identify clinical presentations where testing for auto-antibodies and referral to rheumatology is appropriate
- DMARDs and Biologics in management of rheumatic diseases: current state of understanding.
- Recognize the vast number of disease modifying anti-rheumatic drugs (DMARDs) and biologic response modifiers (Biologics) used in management of rheumatic diseases.
- Differentiate various pharmacological features of DMARDs and Biologics.
- Summarize regulatory and financial issues with biologics and biosimilars.
- Systemic Lupus Erythematosus (SLE/Lupus): An Overview
- Identify various clinical presentations and classification of Systemic Lupus Erythematosus (SLE).
- Describe the common agents and evidence based strategies in management of Lupus (SLE).
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.